Learning the hard way: the effect of violent conflict on student academic achievement af Brück, T, Di Maio, M, Miaari, S

HEALTH-CARE RESOURCE UTILIZATION IN ADVANCED MELANOMA: AN ANALYSIS FROM THE MELODY OBSERVATIONAL STUDY af Lorigan, P, Maio, M, Middleton, M, Testori, A, Bedane, C, van Baardewijk, M, Konto, C, Dueymes, A, Lebbe, C

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: A retrospective, longitudinal survey (MELODY study) af Lebbe, C, Lorigan, P, Ascierto, P, Testori, A, Bédane, C, Middleton, M, Van Baardewijk, M, Konto, C, Dueymes, A, Maio, M

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study). af Lebbe, C, Lorigan, P, Ascierto, P, Testori, A, Bédane, C, Middleton, M, van Baardewijk, M, Konto, C, Dueymes, A, Maio, M

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective,... af Johnston, K, Levy, A, Lorigan, P, Maio, M, Lebbe, C, Middleton, M, Testori, A, Bédane, C, Konto, C, Dueymes, A, Sbarigia, U, van Baardewijk, M

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective,... af Johnston, K, Levy, A, Lorigan, P, Maio, M, Lebbe, C, Middleton, M, Testori, A, Bédane, C, Konto, C, Dueymes, A, Sbarigia, U, van Baardewijk, M

Adjuvant nivolumab (NIVO) versus ipilimumab (IPI) in resected stage III/IV melanoma: 3-year efficacy and biomarker results from the phase III CheckMate 238 trial af Weber, J, Del Vecchio, M, Mandala, M, Gogas, H, Arance, A, Dalle, S, Cowey, C, Schenker, M, Grob, J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, M, Maio, M, Middleton, M, Tang, T, Saci, A, De Pril, V, Lobo, M, Larkin, J, Ascierto, P